John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Trump Says Anthropic No Longer Seen as National Security Threat 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
BOWIE, Md., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based analytics and data-driven intervention platforms to the healthcare industry, today announced that it will host an Investor Day in New York City from 1:00 p.m. to 5:30 p.m. EST on Monday, December 7, 2015. Senior leaders will provide an overview and discussion of the Company’s market, capabilities, financial metrics and long-term goals.
A webcast of the event will be broadcast simultaneously on the Investor Relations section of Inovalon’s website at www.inovalon.com. A replay of the event, as well as a copy of presentation materials, will be available on the website following the event.
About Inovalon
Inovalon is a leading technology company that combines advanced, cloud-based data analytics, and data-driven intervention platforms, to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 777,000 physicians, 266,000 clinical facilities, and more than 127 million Americans. Through these capabilities, and those of its subsidiary Avalere Health, Inc., which offers data-driven advisory services and business intelligence to more than 200 pharmaceutical and life sciences enterprises, Inovalon is able to drive high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. For more information, visit www.inovalon.com.
Contact: Inovalon Kim E. Collins Phone: 301-809-4000 x1473 [email protected]
